Search for: "Dole Land Company, Inc." Results 21 - 26 of 26
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Nov 2009, 1:41 am
IP Think Tank Podcast 22 October 2009 (IP Think Tank) Systemic risks to IP and intangible assets (Business IP and Intangible Assets Report and Blog) Systemic risks to IP and intangible assets held by SME’s and SMM’s (Business IP and Intangible Assets Report and Blog) Converging and bundling intangible assets to meet company’s core mission (Business IP and Intangible Assets Report and Blog) Intangible asset risk management – the 4G of information asset… [read post]
2 Nov 2009, 1:41 am
Group, Inc v Jungle Networks, Inc (Gray on Claims) BPAI holds term indefinite and summarizes reasoning behind broadest reasonable interpretation rule: Ex parte Senju Metal Industry Co (Gray on Claims) US Patents - Lawsuits and strategic steps Amkor Technology - ITC issues supplemental initial determination finding non-invalidity under 35 USC §§ 102(g) and 103(a) of certain asserted patent claims in investigation concerning Carsem's importation and sale of… [read post]
1 Nov 2008, 3:12 am
(Spicy IP) Allegations of corruption at the IPO - the AWS report on IP in India: the good, the bad and the ugly (Spicy IP) Critical review of New York Times article on Bayh Dole Act (Spicy IP) Indian Bayh Dole Bill: secret 'public' discussions by FICCI? [read post]
9 May 2013, 1:48 am by Editors
Is it time to dust off your employee handbook? [read post]
9 May 2013, 1:48 am by Editors
Is it time to dust off your employee handbook? [read post]
18 Jul 2008, 8:34 am
: (GenericsWeb), Eularis analyses most effective generics defence strategies with new pharmaceutical industry report: (GenericsWeb), WIPO symposium to discuss life sciences multilateral environmental agreements: (Daily Dose of IP), Daiichi Sankyo and Ranbaxy confirm deal is binding and final, allay market rumour and speculation: (SmartBrief), Daiichi Ranbaxy takeover and the implications for the future of IP: (Spicy IP), Europe: Cancer Research Therapeutics’ RNAi patent revoked by EPO:… [read post]